Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Stomatitis 1Squamous Cell Carcinoma of Head and Neck 1Pain 1Breast Neoplasms 1

Interventions

Low-Level Light Therapy 14Fibroblast Growth Factor 7 10Cisplatin 6Standard of Care 5avasopasem manganese 4Radiotherapy, Intensity-Modulated 4Propolis 4Mouthwashes 4Cryotherapy 4Water 3Sodium Bicarbonate 3Saline Solution 3Radiotherapy 3Laser Therapy 3Injections 3Drug Therapy 3Control Groups 3Benzydamine 3golotimod 2aluminum hydroxide, magnesium hydroxide, drug combination 2Xylitol 2Vitamin E 2Vitamin B 12 2Sodium Chloride 2Saliva, Artificial 2RRx-001 2Practice Guidelines as Topic 2Lidocaine 2Honey 2Glutamine 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Stomatitis × Amidines × Clear all
NCT02531906 2022-07-25

Gabapentin, Methadone Hydrochloride, and Oxycodone Hydrochloride in Improving Quality of Life in Patients With Stage II-IV Head and Neck Cancer During Chemoradiation

Roswell Park Cancer Institute

Phase 1 Completed
60 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Pain, Stomatitis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡